Atlas Trials

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Clinical trial NCT06593782 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06593782
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nausea and Vomiting, Chemotherapy-Induced
Start date
2024-09-16
Primary completion
2025-06-11
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.